0.5mg Dactinomycin For Injection Usp

Get a Price/Quote

MOQ : 10 Boxes

0.5mg Dactinomycin For Injection Usp Specification

Salt Composition
Dactinomycin (0.5mg) USP

Dosage Form
Lyophilized Powder for Injection

Indication
Treatment of various cancers including Wilms tumor, rhabdomyosarcoma, Ewings sarcoma, and gestational trophoblastic neoplasia

Feature
High purity, sterile, ready for reconstitution, High purity, sterile, single-dose vial

Ingredients
Dactinomycin, excipients, Dactinomycin

Application
Intravenous administration only

Ph Level
Neutral (typically adjusted to pH 7.0-7.5 after reconstitution)

Physical Color/Texture
Yellow to orange lyophilized powder, Yellow, lyophilized powder

Fermentation Smell
Odorless, Odorless

Storage Instructions
Store below 25C, protect from light

Shelf Life
24 months

Regulatory Status
US FDA and other major regulatory approvals

Prescription Status
Prescription only (Rx)

Container Material
Type I glass vial with rubber stopper and aluminum seal

Precautions
For use by qualified medical professionals only; Cytotoxic. Handle with care.

Strength
0.5 mg per vial

Compatibility
Compatible with 0.9% sodium chloride and 5% dextrose solution for reconstitution

Reconstitution Instructions
Reconstitute with 1.1 mL sterile water for injection to yield 0.5 mg/mL solution

Contraindications
Hypersensitivity to Dactinomycin, active infections, severe hepatic dysfunction

Administration Route
Intravenous (IV) only, must not be administered by other routes

Packaging Size
Single-use vial, available in box containing 1 vial

0.5mg Dactinomycin For Injection Usp Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 0.5mg Dactinomycin For Injection Usp

Experience the valiant precision of 0.5mg Dactinomycin For Injection USP, a classic intravenous chemotherapy agent designed for the treatment of ravishingly challenging cancers such as Wilms tumor, rhabdomyosarcoma, Ewings sarcoma, and gestational trophoblastic neoplasia. This customizable injectable comes as a fresh, yellow lyophilized powder in a high-purity, single-use Type I glass vial, redeeming clinical standards with US FDA approval. Easy to reconstitute and compatible with common IV solutions, it guarantees optimal sterility, efficacy, and safety. Available exclusively on prescription for qualified professionals.

Directions, Advantage, and Clinical Applicability

0.5mg Dactinomycin For Injection USP is administered intravenously and is never to be used by other routes. Recognized for its high purity and sterile preparation, the drug excels in treating a spectrum of malignancies. Ready for rapid reconstitution with sterile water, it benefits from a neutral pH, ensuring content stability and patient safety. Every vial is designed for single-use, supporting meticulous dosing and safeguarding against contamination during administration.

Export Policy, Delivery & Sample Process

Serving as a trusted exporter, supplier, and trader from India, we cater to major international markets with prompt, secure dispatches. Delivery of 0.5mg Dactinomycin is streamlined to drive cost-efficient shipment, ensuring timely receipt and optimal product integrity. Sample policies are tailored to minimize expenditure while allowing clients to evaluate quality; samples are available and promptly dispatched upon request under regulated conditions to maintain compliance and reliability.

FAQ's of 0.5mg Dactinomycin For Injection Usp:

Q: How should 0.5mg Dactinomycin For Injection USP be administered?

A: This medication must be administered exclusively by intravenous (IV) infusion after proper reconstitution with sterile water. It must not be given by any other route.

Q: What are the main indications for the use of Dactinomycin Injection?

A: Dactinomycin is indicated for the treatment of various cancers, including Wilms tumor, rhabdomyosarcoma, Ewings sarcoma, and gestational trophoblastic neoplasia.

Q: When is it contraindicated to use this drug?

A: Dactinomycin use is contraindicated in patients with hypersensitivity to dactinomycin, those with active infections, or severe hepatic dysfunction.

Q: Where can healthcare professionals find reconstitution instructions?

A: Detailed reconstitution instructions are provided with each vial, specifying that 1.1 mL sterile water is required to yield 0.5 mg/mL solution. Compatibility with 0.9% sodium chloride and 5% dextrose is also indicated.

Q: What are the key benefits of this injection for medical professionals?

A: Medical professionals benefit from its high purity, readiness for reconstitution, neutral pH, secure packaging, and regulatory approvals, ensuring both efficacy and safety for cancer patients.

Q: How quickly are samples dispatched for international buyers?

A: Samples are readily available and dispatched as per the sample policy, ensuring minimal delivery delays and compliance with all international regulatory standards.

Tell us about your requirement